Avenir Corp Cytosorbents Corp Put Options Transaction History
Avenir Corp
- $922 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CTSO
# of Institutions
52Shares Held
16.7MCall Options Held
28.9KPut Options Held
0-
Skylands Capital, LLC2.62MShares$2.77 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$2.25 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.59MShares$1.69 Million0.0% of portfolio
-
Cm Management, LLC1.25MShares$1.33 Million1.64% of portfolio
-
Sargent Investment Group, LLC746KShares$790,9720.14% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $46.2M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...